chrX-21426508-T-C
Variant names:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_014927.5(CNKSR2):c.76T>C(p.Cys26Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 23)
Consequence
CNKSR2
NM_014927.5 missense
NM_014927.5 missense
Scores
10
5
2
Clinical Significance
Conservation
PhyloP100: 5.88
Genes affected
CNKSR2 (HGNC:19701): (connector enhancer of kinase suppressor of Ras 2) This gene encodes a multidomain protein that functions as a scaffold protein to mediate the mitogen-activated protein kinase pathways downstream from Ras. This gene product is induced by vitamin D and inhibits apoptosis in certain cancer cells. It may also play a role in ternary complex assembly of synaptic proteins at the postsynaptic membrane and coupling of signal transduction to membrane/cytoskeletal remodeling. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.856
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD4 exome Cov.: 28
GnomAD4 exome
Cov.:
28
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Intellectual disability, X-linked, syndromic, Houge type Uncertain:1
Apr 04, 2024
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;.;.;.;.;.;.;.;.;D;.;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.;M;.;M;.;.;.;.;.;M;.;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;.;D;.;D;D;.;.;.;.;D;.;.
REVEL
Pathogenic
Sift
Uncertain
.;.;D;.;D;D;.;.;.;.;D;.;.
Sift4G
Uncertain
.;.;D;.;D;D;.;.;.;.;D;.;.
Polyphen
0.99
.;.;.;.;.;.;.;.;.;.;D;.;.
Vest4
0.78, 0.79, 0.83, 0.80
MutPred
Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);Gain of MoRF binding (P = 0.0124);
MVP
0.92
MPC
2.4
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.